Barclays: ‘New Advances in the Biology of Aging’

As part of the ‘Beyond 100’ program from November 2018, Barclays released a video discussing the science of longevity and the implications of living until 120 years old.

Jim Mellon , Chairman of Juvenescence, discusses in the video how science is elucidating the fundamental biological mechanisms of aging, and taking strides to manipulate the cellular processes leading to age-related diseases.

Michael D. West , CEO of our partner AgeX Therapeutics, Inc. discusses how stem cell therapies could be used for repairing aged tissues and treating degenerative diseases that accompany old age.

Read the report at Barclays.